ALEC logo

Alector (ALEC)

Profile

Full Name

Alector, Inc.

Ticker Symbol

ALEC

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 7, 2019

Indexes

Not included

Website

http://www.alector.com

Employees

238

Key Details

Price

$0.92(-5.93%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$100.56M(+3.60% YoY)

Annual EPS

-$1.23(+21.15% YoY)

PE ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.92
ALEC price is $0.92

30-Day Relative Volume

0.78
ALEC 30-day relative volume is 0.78

Price Performance

Price Most recent change

-5.93%
ALEC price was down -5.93% on Apr 17, 2025

Price YTD change

-51.32%
ALEC price is down -51.32% since January 1st

Price 1-year change

-81.85%
ALEC price is down -81.85% year-on-year

Price 3-year change

-91.98%
ALEC price is down -91.98% over the past 3 years

Price Range

Price All-time high

$43.32
ALEC price is currently -97.88% below its historical high of $43.32

Price 3-year low

$0.87
ALEC price is currently +5.75% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$91.16M
ALEC market capitalization is $91.16 million

Market cap 3-year change

-90.34%
ALEC market capitalization is down -90.34% over the past 3 years

Market cap All-time high

$3.16B
ALEC market capitalization is currently -97.11% below its historical high of $3.16 billion

Market cap sector rank

47.49%
ALEC market capitalization is higher than 47.49% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+2.8%
ALEC shares outstanding is up +2.8% year-on-year

Shares Outstanding 3-Year Change

+20.36%
ALEC shares outstanding is up +20.36% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.35
ALEC beta is 1.35

200-day SMA

$3.45
ALEC price is currently -73.35% below its 200-day simple moving average

50-day SMA

$1.40
ALEC price is currently -34.27% below its 50-day simple moving average

RSI

33.73
ALEC 14-day relative strength index is 33.73

Volume

0.78
ALEC 30-day relative volume is 0.78

ATR

$0.11
ALEC average true range is $0.11

10-day Historical Volatility

106.14%
ALEC 10-day historical volatility is 106.14%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$100.56M
ALEC annual revenue is $100.56 million

Revenue Analysts estimate

$14.13M
ALEC annual revenue is currently +611.92% higher than the consensus analysts' forecast

Revenue 1-year change

+3.6%
ALEC annual revenue is up +3.6% year-on-year

Revenue Sector rank

56.28%
ALEC annual revenue is higher than 56.28% of companies in Healthcare sector

EPS

EPS

-$1.23
ALEC annual earnings per share is -$1.23

EPS Analysts estimate

-$1.97
ALEC annual earnings per share is currently -37.69% lower than the consensus analysts' forecast

EPS 1-year change

+21.15%
ALEC annual earnings per share is up +21.15% year-on-year

EPS Sector rank

51.12%
ALEC annual earnings per share is higher than 51.12% of companies in Healthcare sector

Profit

Gross profit

-
ALEC annual gross profit value is unknown

Gross margin

-
ALEC annual gross profit margin value is unknown

Operating profit

-$145.00M
ALEC annual operating income is -$145.00 million

Operating margin

-144.19%
ALEC annual operating profit margin is -144.19%

Net income

-$119.05M
ALEC annual net profit is -$119.05 million

Net margin

-118.39%
ALEC annual net profit margin is -118.39%

Expenses

Total expenses

$245.56M
ALEC annual total expenses is $245.56 million

Operating expenses

$245.56M
ALEC annual total operating expenses is $245.56 million

Cost of goods sold

-
ALEC annual cost of goods sold value is unknown

Selling, general & administrative expenses

$59.62M
ALEC annual SGA is $59.62 million

Depreciation and amortization

$8.84M
ALEC annual depreciation & amortization is $8.84 million

Interest expense

-
ALEC annual interest expense value is unknown

Income tax

$128.00K
ALEC annual income tax is $128.00 thousand

EBIT & EBITDA

EBIT

-$145.00M
ALEC annual earnings before interest & taxes is -$145.00 million

EBITDA

-$136.16M
ALEC annual EBITDA is -$136.16 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$468.30M
ALEC annual total assets is $468.30 million

Non current assets

$43.49M
ALEC annual long term assets is $43.49 million

Current assets

$424.82M
ALEC annual total current assets is $424.82 million

Cash and cash equivalents

$33.02M
ALEC annual cash & cash equivalents is $33.02 million

Accounts receivable

-
ALEC annual accounts receivable value is unknown

Inventory

-
ALEC annual inventory value is unknown

Liabilities

Total liabilities

$341.50M
ALEC annual total liabilities is $341.50 million

Long term liabilities

$216.44M
ALEC annual total long term liabilities is $216.44 million

Current liabilities

$125.06M
ALEC annual total current liabilities is $125.06 million

Accounts payable

$2.21M
ALEC annual accounts payable is $2.21 million

Debt

Total debt

$42.52M
ALEC annual total debt is $42.52 million

Total debt 1-year change

+9.25%
ALEC annual total debt is up +9.25% year-on-year

Long term debt

$33.77M
ALEC annual long term debt is $33.77 million

Short term debt

$8.75M
ALEC annual short term debt is $8.75 million

Equity & Capital

Shareholders equity

$126.80M
ALEC annual stockholders equity is $126.80 million

Book value

$126.80M
ALEC annual book value is $126.80 million

Retained earnings

-$829.13M
ALEC annual retained earnings is -$829.13 million

Working capital

$299.76M
ALEC annual working capital is $299.76 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$229.91M
ALEC annual cash flow from operations is -$229.91 million

Cash from operations 1-year change

-24.84%
ALEC annual cash flow from operations is down -24.84% year-on-year

Cash from investing

$107.13M
ALEC annual cash flow from investing activities is $107.13 million

Cash from investing 1-year change

+5.11%
ALEC annual cash flow from investing activities is up +5.11% year-on-year

Cash from financing

$81.54M
ALEC annual cash flow from financing activities is $81.54 million

Cash from financing 1-year change

+3097.65%
ALEC annual cash flow from financing activities is up +3097.65% year-on-year

CAPEX

CAPEX

$1.25M
ALEC annual capital expenditures is $1.25 million

CAPEX 1-year change

-47.29%
ALEC annual capital expenditures is down -47.29% year-on-year

Free Cash Flow

Free cash flow

-$231.16M
ALEC annual free cash flow is -$231.16 million

Free cash flow 1-year change

-23.92%
ALEC annual free cash flow is down -23.92% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ALEC annual gross profit margin value is unknown

Operating margin

-144.19%
ALEC annual operating profit margin is -144.19%

Net margin

-118.39%
ALEC annual net profit margin is -118.39%

ROA & ROE

ROA

-21.84%
ALEC annual return on assets is -21.84%

ROE

-91.24%
ALEC annual return on equity is -91.24%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ALEC price to earnings ratio value is unknown

PE ratio Sector rank

-
ALEC price to earnings ratio is unknown

PB Ratio

PB ratio

0.72
ALEC price to book ratio is 0.72

PB ratio Sector rank

37.35%
ALEC price to book ratio is higher than 37.35% of companies in Healthcare sector

PS Ratio

PS ratio

0.91
ALEC price to sales ratio is 0.91

PS ratio Sector rank

26.06%
ALEC price to sales ratio is higher than 26.06% of companies in Healthcare sector

Enterprise value

Enterprise value

$100.66M
ALEC enterprise value is $100.66 million

Enterprise value Sector rank

50.17%
ALEC enterprise value is higher than 50.17% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.74
ALEC EV/EBITDA is -0.74

EV/EBITDA Sector rank

47.17%
ALEC EV/EBITDA is higher than 47.17% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.40
ALEC annual current ratio is 3.40

Quick ratio

-
ALEC annual quick ratio value is unknown

Leverage

Debt to equity

0.07
ALEC annual debt to equity ratio is 0.07

Interest coverage ratio

-
ALEC annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
ALEC piotroski f-score value is unknown

Altman Z-Score

-2.36
ALEC altman z-score is -2.36

Analyst ratings

Recent major analysts updates

Feb 27, 25 HC Wainwright & Co.
Buy
Dec 16, 24 Stifel
Hold
Nov 26, 24 Morgan Stanley
Underweight
Nov 26, 24 Cantor Fitzgerald
Overweight
Nov 26, 24 BTIG
Buy
Nov 7, 24 HC Wainwright & Co.
Buy
Sep 17, 24 Cantor Fitzgerald
Overweight
Sep 9, 24 Cantor Fitzgerald
Overweight
Jul 29, 24 Cantor Fitzgerald
Overweight
Jun 20, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

eXoZymes (EXOZ)
Lexeo Therapeutics (LXEO)
ZNTL logo
Zentalis Pharmaceuticals (ZNTL)
XBIT logo
XBiotech (XBIT)
OPTN logo
OptiNose (OPTN)
PLRX logo
Pliant Therapeutics (PLRX)
CCCC logo
C4 Therapeutics (CCCC)
LCTX logo
Lineage Cell Therapeutics (LCTX)
IMUX logo
Immunic (IMUX)
  • What is the ticker symbol for Alector?
  • Does Alector pay dividends?
  • What sector is Alector in?
  • What industry is Alector in?
  • What country is Alector based in?
  • When did Alector go public?
  • Is Alector in the S&P 500?
  • Is Alector in the NASDAQ 100?
  • Is Alector in the Dow Jones?
  • When was Alector's last earnings report?
  • When does Alector report earnings?
  • Should I buy Alector stock now?

What is the ticker symbol for Alector?

The ticker symbol for Alector is NASDAQ:ALEC

Does Alector pay dividends?

No, Alector does not pay dividends

What sector is Alector in?

Alector is in the Healthcare sector

What industry is Alector in?

Alector is in the Biotechnology industry

What country is Alector based in?

Alector is headquartered in United States

When did Alector go public?

Alector's initial public offering (IPO) was on February 7, 2019

Is Alector in the S&P 500?

No, Alector is not included in the S&P 500 index

Is Alector in the NASDAQ 100?

No, Alector is not included in the NASDAQ 100 index

Is Alector in the Dow Jones?

No, Alector is not included in the Dow Jones index

When was Alector's last earnings report?

Alector's most recent earnings report was on Feb 26, 2025

When does Alector report earnings?

The next expected earnings date for Alector is May 8, 2025

Should I buy Alector stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page